spacer
spacer
Go to PDB code: 
protein ligands links
Oxidoreductase PDB id
1po5
Jmol
Contents
Protein chain
465 a.a. *
Ligands
HEM
Waters ×261
* Residue conservation analysis
PDB id:
1po5
Name: Oxidoreductase
Title: Structure of mammalian cytochrome p450 2b4
Structure: Cytochrome p450 2b4. Chain: a. Synonym: cypiib4, p450-lm2, isozyme 2, p450 type b0. Engineered: yes. Mutation: yes
Source: Oryctolagus cuniculus. Rabbit. Organism_taxid: 9986. Gene: 2b4. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Dimer (from PQS)
Resolution:
1.60Å     R-factor:   0.217     R-free:   0.289
Authors: E.E.Scott,Y.A.He,M.R.Wester,M.A.White,C.C.Chin,J.R.Halpert, E.F.Johnson,C.D.Stout
Key ref:
E.E.Scott et al. (2003). An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution. Proc Natl Acad Sci U S A, 100, 13196-13201. PubMed id: 14563924 DOI: 10.1073/pnas.2133986100
Date:
13-Jun-03     Release date:   07-Oct-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P00178  (CP2B4_RABIT) -  Cytochrome P450 2B4
Seq:
Struc:
491 a.a.
465 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.1.14.14.1  - Unspecific monooxygenase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O
RH
+ reduced flavoprotein
+ O(2)
= ROH
+ oxidized flavoprotein
+ H(2)O
      Cofactor: Heme-thiolate
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     membrane   4 terms 
  Biological process     oxidation-reduction process   1 term 
  Biochemical function     electron carrier activity     9 terms  

 

 
    Added reference    
 
 
DOI no: 10.1073/pnas.2133986100 Proc Natl Acad Sci U S A 100:13196-13201 (2003)
PubMed id: 14563924  
 
 
An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution.
E.E.Scott, Y.A.He, M.R.Wester, M.A.White, C.C.Chin, J.R.Halpert, E.F.Johnson, C.D.Stout.
 
  ABSTRACT  
 
The xenobiotic metabolizing cytochromes P450 (P450s) are among the most versatile biological catalysts known, but knowledge of the structural basis for their broad substrate specificity has been limited. P450 2B4 has been frequently used as an experimental model for biochemical and biophysical studies of these membrane proteins. A 1.6-A crystal structure of P450 2B4 reveals a large open cleft that extends from the protein surface directly to the heme iron between the alpha-helical and beta-sheet domains without perturbing the overall P450 fold. This cleft is primarily formed by helices B' to C and F to G. The conformation of these regions is dramatically different from that of the other structurally defined mammalian P450, 2C5/3LVdH, in which the F to G and B' to C regions encapsulate one side of the active site to produce a closed form of the enzyme. The open conformation of 2B4 is trapped by reversible formation of a homodimer in which the residues between helices F and G of one molecule partially fill the open cleft of a symmetry-related molecule, and an intermolecular coordinate bond occurs between H226 and the heme iron. This dimer is observed both in solution and in the crystal. Differences between the structures of 2C5 and 2B4 suggest that defined regions of xenobiotic metabolizing P450s may adopt a substantial range of energetically accessible conformations without perturbing the overall fold. This conformational flexibility is likely to facilitate substrate access, metabolic versatility, and product egress.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. The 2B4 structure and comparison with 2C5. (A) P450 2B4 is oriented to view the large cleft from the protein surface to the heme. The sequence can be traced starting at the blue N terminus and ending at the red C terminus. (B and C) Comparison of 2B4 (B) and 2C5/3LV (1N6B [PDB] ) (C) structures. Residues with the highest rms deviations between the two structures include 2B4 residues 37-50 (helix A' and adjacent residues, magenta), residues 92-140 (helix B C terminus to helix D N terminus, blue), residues 206-250 (C-terminal turn of helix F through helix G, purple), residues 275-300 (loop between helices H and I encompassing a three-residue insertion in 2B4 relative to 2C5 and N-terminal half of helix I, orange), and 474-479 ( turn between L' and [3-2], gray). Excluding these residues, the rms deviation of 324 C^ atoms between 2B4 and 2C5 is 1.08 Å. The heme group is shown as a stick figure, and the iron is shown as a red sphere. N and C termini are labeled. Unless otherwise noted, molecular figures were generated by using PYMOL (28).
Figure 2.
Fig. 2. Comparison of structural elements composing the 2B4 cleft. (A) Clefts in the mammalian 2B4 (green) and the bacterial 154C1 (PDB ID code 1GWI [PDB] , blue) P450s are composed of similar structural elements. (B) In 2B4 (green) helices, F' and G' flex away from the B' helix, whereas in 2C5 (yellow), they extend to form the roof of the active site. For clarity, only the regions including helices B through D, F through G, and I are shown. The heme is shown as a stick figure.
 
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21154803 M.Ma, S.G.Bell, W.Yang, Y.Hao, N.H.Rees, M.Bartlam, W.Zhou, L.L.Wong, and Z.Rao (2011).
Structural Analysis of CYP101C1 from Novosphingobium aromaticivorans DSM12444.
  Chembiochem, 12, 88-99.
PDB codes: 3oft 3ofu
21058395 W.Li, J.Shen, G.Liu, Y.Tang, and T.Hoshino (2011).
Exploring coumarin egress channels in human cytochrome P450 2A6 by random acceleration and steered molecular dynamics simulations.
  Proteins, 79, 271-281.  
21171581 Y.T.Lee, E.C.Glazer, R.F.Wilson, C.D.Stout, and D.B.Goodin (2011).
Three clusters of conformational States in p450cam reveal a multistep pathway for closing of the substrate access channel .
  Biochemistry, 50, 693-703.  
19635450 H.Ouellet, J.B.Johnston, and P.R.Ortiz de Montellano (2010).
The Mycobacterium tuberculosis cytochrome P450 system.
  Arch Biochem Biophys, 493, 82-95.  
20096935 N.N.Bumpus, and P.F.Hollenberg (2010).
Cross-linking of human cytochrome P450 2B6 to NADPH-cytochrome P450 reductase: Identification of a potential site of interaction.
  J Inorg Biochem, 104, 485-488.  
19947890 N.Shakunthala (2010).
New cytochrome P450 mechanisms: implications for understanding molecular basis for drug toxicity at the level of the cytochrome.
  Expert Opin Drug Metab Toxicol, 6, 1.  
20697922 O.Shoji, T.Fujishiro, S.Nagano, S.Tanaka, T.Hirose, Y.Shiro, and Y.Watanabe (2010).
Understanding substrate misrecognition of hydrogen peroxide dependent cytochrome P450 from Bacillus subtilis.
  J Biol Inorg Chem, 15, 1331-1339.
PDB codes: 2zqj 2zqx
20361239 R.J.Unwalla, J.B.Cross, S.Salaniwal, A.D.Shilling, L.Leung, J.Kao, and C.Humblet (2010).
Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism.
  J Comput Aided Mol Des, 24, 237-256.  
20061448 S.C.Gay, M.B.Shah, J.C.Talakad, K.Maekawa, A.G.Roberts, P.R.Wilderman, L.Sun, J.Y.Yang, S.C.Huelga, W.X.Hong, Q.Zhang, C.D.Stout, and J.R.Halpert (2010).
Crystal structure of a cytochrome P450 2B6 genetic variant in complex with the inhibitor 4-(4-chlorophenyl)imidazole at 2.0-A resolution.
  Mol Pharmacol, 77, 529-538.
PDB code: 3ibd
20446763 T.C.Pochapsky, S.Kazanis, and M.Dang (2010).
Conformational plasticity and structure/function relationships in cytochromes P450.
  Antioxid Redox Signal, 13, 1273-1296.  
20297780 Y.T.Lee, R.F.Wilson, I.Rupniewski, and D.B.Goodin (2010).
P450cam visits an open conformation in the absence of substrate.
  Biochemistry, 49, 3412-3419.
PDB codes: 3l61 3l62 3l63
19208235 A.Fischer, N.Enkler, G.Neudert, M.Bocola, R.Sterner, and R.Merkl (2009).
TransCent: computational enzyme design by transferring active sites and considering constraints relevant for catalysis.
  BMC Bioinformatics, 10, 54.  
19199046 C.R.McCullough, P.K.Pullela, S.C.Im, L.Waskell, and D.S.Sem (2009).
(13)C-Methyl isocyanide as an NMR probe for cytochrome P450 active sites.
  J Biomol NMR, 43, 171-178.  
19728720 D.Fishelovitch, S.Shaik, H.J.Wolfson, and R.Nussinov (2009).
Theoretical characterization of substrate access/exit channels in the human cytochrome P450 3A4 enzyme: involvement of phenylalanine residues in the gating mechanism.
  J Phys Chem B, 113, 13018-13025.  
19700628 H.L.Lin, H.Zhang, K.R.Noon, and P.F.Hollenberg (2009).
Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein.
  J Pharmacol Exp Ther, 331, 392-403.  
19605359 H.Zhang, C.Kenaan, D.Hamdane, G.H.Hoa, and P.F.Hollenberg (2009).
Effect of conformational dynamics on substrate recognition and specificity as probed by the introduction of a de novo disulfide bond into cytochrome P450 2B1.
  J Biol Chem, 284, 25678-25686.  
19074393 L.H.Xu, S.Fushinobu, H.Ikeda, T.Wakagi, and H.Shoun (2009).
Crystal structures of cytochrome P450 105P1 from Streptomyces avermitilis: conformational flexibility and histidine ligation state.
  J Bacteriol, 191, 1211-1219.
PDB codes: 3e5j 3e5k 3e5l
19265398 S.Balaz (2009).
Modeling kinetics of subcellular disposition of chemicals.
  Chem Rev, 109, 1793-1899.  
19397311 S.C.Gay, L.Sun, K.Maekawa, J.R.Halpert, and C.D.Stout (2009).
Crystal structures of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole: ligand-induced structural response through alpha-helical repositioning.
  Biochemistry, 48, 4762-4771.
PDB codes: 3g5n 3g93
18470941 G.Chavarria-Soley, H.Sticht, E.Aklillu, M.Ingelman-Sundberg, F.Pasutto, A.Reis, and B.Rautenstrauss (2008).
Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzyme.
  Hum Mutat, 29, 1147-1153.  
18026129 J.D.Maréchal, C.A.Kemp, G.C.Roberts, M.J.Paine, C.R.Wolf, and M.J.Sutcliffe (2008).
Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions.
  Br J Pharmacol, 153, S82-S89.  
18976212 K.N.Myasoedova (2008).
New findings in studies of cytochromes P450.
  Biochemistry (Mosc), 73, 965-969.  
18787124 L.Li, Z.Chang, Z.Pan, Z.Q.Fu, and X.Wang (2008).
Modes of heme binding and substrate access for cytochrome P450 CYP74A revealed by crystal structures of allene oxide synthase.
  Proc Natl Acad Sci U S A, 105, 13883-13888.
PDB codes: 3dam 3dan 3dbm
18453684 M.A.White, N.Mast, I.Bjorkhem, E.F.Johnson, C.D.Stout, and I.A.Pikuleva (2008).
Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P450 46A1.
  Acta Crystallogr D Biol Crystallogr, 64, 487-495.  
18621926 N.N.Bumpus, and P.F.Hollenberg (2008).
Investigation of the mechanisms underlying the differential effects of the K262R mutation of P450 2B6 on catalytic activity.
  Mol Pharmacol, 74, 990-999.  
18495666 N.Oezguen, S.Kumar, A.Hindupur, W.Braun, B.K.Muralidhara, and J.R.Halpert (2008).
Identification and analysis of conserved sequence motifs in cytochrome P450 family 2. Functional and structural role of a motif 187RFDYKD192 in CYP2B enzymes.
  J Biol Chem, 283, 21808-21816.  
18338380 R.K.Hughes, F.K.Yousafzai, R.Ashton, I.R.Chechetkin, S.A.Fairhurst, M.Hamberg, and R.Casey (2008).
Evidence for communality in the primary determinants of CYP74 catalysis and of structural similarities between CYP74 and classical mammalian P450 enzymes.
  Proteins, 72, 1199-1211.  
18729327 U.M.Kent, C.Sridar, G.Spahlinger, and P.F.Hollenberg (2008).
Modification of serine 360 by a reactive intermediate of 17-alpha-ethynylestradiol results in mechanism-based inactivation of cytochrome P450s 2B1 and 2B6.
  Chem Res Toxicol, 21, 1956-1963.  
18004755 W.Li, Y.Tang, H.Liu, J.Cheng, W.Zhu, and H.Jiang (2008).
Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking.
  Proteins, 71, 938-949.  
18366166 Y.Ding, W.H.Seufert, Z.Q.Beck, and D.H.Sherman (2008).
Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
  J Am Chem Soc, 130, 5492-5498.  
18270198 Y.T.Meharenna, K.E.Slessor, S.M.Cavaignac, T.L.Poulos, and J.J.De Voss (2008).
The critical role of substrate-protein hydrogen bonding in the control of regioselective hydroxylation in p450cin.
  J Biol Chem, 283, 10804-10812.
PDB codes: 3bdz 3be0
18511451 Y.Wada, M.Mitsuda, Y.Ishihara, M.Watanabe, M.Iwasaki, and S.Asahi (2008).
Important amino acid residues that confer CYP2C19 selective activity to CYP2C9.
  J Biochem, 144, 323-333.  
  18607105 Z.Chang, L.Li, Z.Pan, and X.Wang (2008).
Crystallization and preliminary X-ray analysis of allene oxide synthase, cytochrome P450 CYP74A2, from Parthenium argentatum.
  Acta Crystallogr Sect F Struct Biol Cryst Commun, 64, 668-670.  
17573904 A.Baradaran-Heravi, R.Vakili, T.Robins, J.Carlsson, N.Ghaemi, A.A'rabi, and M.R.Abbaszadegan (2007).
Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
  Clin Endocrinol (Oxf), 67, 335-341.  
17207766 A.J.Annalora, E.Bobrovnikov-Marjon, R.Serda, A.Pastuszyn, S.E.Graham, C.B.Marcus, and J.L.Omdahl (2007).
Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.
  Arch Biochem Biophys, 460, 262-273.  
17534532 A.W.Munro, H.M.Girvan, and K.J.McLean (2007).
Variations on a (t)heme--novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily.
  Nat Prod Rep, 24, 585-609.  
17459323 H.C.Yeh, A.L.Tsai, and L.H.Wang (2007).
Reaction mechanisms of 15-hydroperoxyeicosatetraenoic acid catalyzed by human prostacyclin and thromboxane synthases.
  Arch Biochem Biophys, 461, 159-168.  
17274942 H.Fernando, D.R.Davydov, C.C.Chin, and J.R.Halpert (2007).
Role of subunit interactions in P450 oligomers in the loss of homotropic cooperativity in the cytochrome P450 3A4 mutant L211F/D214E/F304W.
  Arch Biochem Biophys, 460, 129-140.  
17156750 J.P.Harrelson, K.R.Henne, D.O.Alonso, and S.D.Nelson (2007).
A comparison of substrate dynamics in human CYP2E1 and CYP2A6.
  Biochem Biophys Res Commun, 352, 843-849.  
17254539 L.Sun, C.S.Chen, D.J.Waxman, H.Liu, J.R.Halpert, and S.Kumar (2007).
Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide.
  Arch Biochem Biophys, 458, 167-174.  
17705402 P.Lafite, F.André, D.C.Zeldin, P.M.Dansette, and D.Mansuy (2007).
Unusual regioselectivity and active site topology of human cytochrome P450 2J2.
  Biochemistry, 46, 10237-10247.  
18005930 S.G.Rupasinghe, H.Duan, H.L.Frericks Schmidt, D.A.Berthold, C.M.Rienstra, and M.A.Schuler (2007).
High-yield expression and purification of isotopically labeled cytochrome P450 monooxygenases for solid-state NMR spectroscopy.
  Biochim Biophys Acta, 1768, 3061-3070.  
17222385 S.L.Collom, A.P.Jamakhandi, A.J.Tackett, A.Radominska-Pandya, and G.P.Miller (2007).
CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling.
  Arch Biochem Biophys, 459, 59-69.  
17540336 S.Sansen, M.H.Hsu, C.D.Stout, and E.F.Johnson (2007).
Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants.
  Arch Biochem Biophys, 464, 197-206.
PDB codes: 2pg5 2pg6 2pg7
17198380 T.N.Tsalkova, N.Y.Davydova, J.R.Halpert, and D.R.Davydov (2007).
Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probe.
  Biochemistry, 46, 106-119.  
17638512 U.M.Zanger, K.Klein, T.Saussele, J.Blievernicht, M.H.Hofmann, and M.Schwab (2007).
Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.
  Pharmacogenomics, 8, 743-759.  
17529885 Y.J.Jang, E.Y.Cha, W.Y.Kim, S.W.Park, J.H.Shon, S.S.Lee, and J.G.Shin (2007).
CYP2S1 gene polymorphisms in a Korean population.
  Ther Drug Monit, 29, 292-298.  
17887776 Y.Zhao, L.Sun, B.K.Muralidhara, S.Kumar, M.A.White, C.D.Stout, and J.R.Halpert (2007).
Structural and thermodynamic consequences of 1-(4-chlorophenyl)imidazole binding to cytochrome P450 2B4.
  Biochemistry, 46, 11559-11567.
PDB code: 2q6n
16395678 A.D.Favia, A.Cavalli, M.Masetti, A.Carotti, and M.Recanatini (2006).
Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes.
  Proteins, 62, 1074-1087.
PDB code: 1tqa
16639745 A.Seifert, S.Tatzel, R.D.Schmid, and J.Pleiss (2006).
Multiple molecular dynamics simulations of human p450 monooxygenase CYP2C9: the molecular basis of substrate binding and regioselectivity toward warfarin.
  Proteins, 64, 147-155.  
17027909 C.E.Hernandez, S.Kumar, H.Liu, and J.R.Halpert (2006).
Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme.
  Arch Biochem Biophys, 455, 61-67.  
16825192 D.H.Sherman, S.Li, L.V.Yermalitskaya, Y.Kim, J.A.Smith, M.R.Waterman, and L.M.Podust (2006).
The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae.
  J Biol Chem, 281, 26289-26297.
PDB codes: 2bvj 2c6h 2c7x 2cd8
16492736 J.Kim, and D.DellaPenna (2006).
Defining the primary route for lutein synthesis in plants: the role of Arabidopsis carotenoid beta-ring hydroxylase CYP97A3.
  Proc Natl Acad Sci U S A, 103, 3474-3479.  
16700545 J.T.Pearson, J.J.Hill, J.Swank, N.Isoherranen, K.L.Kunze, and W.M.Atkins (2006).
Surface plasmon resonance analysis of antifungal azoles binding to CYP3A4 with kinetic resolution of multiple binding orientations.
  Biochemistry, 45, 6341-6353.  
16541276 M.Barbaro, L.Baldazzi, A.Balsamo, S.Lajic, T.Robins, L.Barp, P.Pirazzoli, E.Cacciari, A.Cicognani, and A.Wedell (2006).
Functional studies of two novel and two rare mutations in the 21-hydroxylase gene.
  J Mol Med, 84, 521-528.  
16954191 M.Ekroos, and T.Sjögren (2006).
Structural basis for ligand promiscuity in cytochrome P450 3A4.
  Proc Natl Acad Sci U S A, 103, 13682-13687.
PDB codes: 2j0c 2j0d 2v0m
16793528 M.J.de Groot (2006).
Designing better drugs: predicting cytochrome P450 metabolism.
  Drug Discov Today, 11, 601-606.  
16963504 M.S.Achary, A.B.Reddy, S.Chakrabarti, S.G.Panicker, A.K.Mandal, N.Ahmed, D.Balasubramanian, S.E.Hasnain, and H.A.Nagarajaram (2006).
Disease-causing mutations in proteins: structural analysis of the CYP1B1 mutations causing primary congenital glaucoma in humans.
  Biophys J, 91, 4329-4339.  
17009958 N.V.Strushkevich, I.N.Harnastai, G.I.Lepesheva, and S.A.Usanov (2006).
Role of C-terminal sequence of cytochrome P450scc in folding and functional activity.
  Biochemistry (Mosc), 71, 1027-1034.  
16897083 T.Uno, A.Nakao, S.Masuda, Y.Taniguchi, K.Kanamaru, H.Yamagata, M.Nakamura, H.Imaishi, and K.Oono (2006).
Modification of small molecules by using cytochrome P450 expressed in Escherichia coli.
  J Ind Microbiol Biotechnol, 33, 1043-1050.  
16485904 U.M.Kent, H.L.Lin, D.E.Mills, K.A.Regal, and P.F.Hollenberg (2006).
Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6.
  Chem Res Toxicol, 19, 279-287.  
15653318 E.E.Scott, and J.R.Halpert (2005).
Structures of cytochrome P450 3A4.
  Trends Biochem Sci, 30, 5-7.  
16163453 E.Hazai, Z.Bikádi, M.Simonyi, and D.Kupfer (2005).
Association of cytochrome P450 enzymes is a determining factor in their catalytic activity.
  J Comput Aided Mol Des, 19, 271-285.  
16028060 J.Bojunga, C.Welsch, I.Antes, M.Albrecht, T.Lengauer, and S.Zeuzem (2005).
Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21-hydroxylase deficiency.
  Hum Genet, 117, 558-564.  
15617063 J.Mestres (2005).
Structure conservation in cytochromes P450.
  Proteins, 58, 596-609.  
15832443 M.J.Coon (2005).
Cytochrome P450: nature's most versatile biological catalyst.
  Annu Rev Pharmacol Toxicol, 45, 1.  
15854816 N.Bistolas, U.Wollenberger, C.Jung, and F.W.Scheller (2005).
Cytochrome P450 biosensors-a review.
  Biosens Bioelectron, 20, 2408-2423.  
15861034 S.S.Lee, H.E.Jeong, K.H.Liu, J.Y.Ryu, T.Moon, C.N.Yoon, S.J.Oh, C.H.Yun, and J.G.Shin (2005).
Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity.
  Pharmacogenet Genomics, 15, 105-113.  
15832445 W.M.Atkins (2005).
Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.
  Annu Rev Pharmacol Toxicol, 45, 291-310.  
15149623 W.M.Atkins (2004).
Implications of the allosteric kinetics of cytochrome P450s.
  Drug Discov Today, 9, 478-484.  
14597705 T.L.Poulos (2003).
Cytochrome P450 flexibility.
  Proc Natl Acad Sci U S A, 100, 13121-13122.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.